Panzyga (human immune globulin intravenous 10% stabilised with glycine) / Octapharma  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Panzyga (human immune globulin intravenous 10% stabilised with glycine) / Octapharma
NCT01300728: Study of Intravenous Immunoglobulin in Amnestic Mild Cognitive Impairment

Completed
2
52
US
NewGam 10% IVIG, Placebo
Sutter Health
Mild Cognitive Impairment
03/20
03/20
NCT04153422: IVIG in the Treatment of Autoimmune Small Fiber Neuropathy With TS-HDS, FGFR-3, or Plexin D1 Antibodies

Recruiting
2
20
US
Panzyga IVIG, Placebo
Henry Ford Health System, Octapharma USA, Inc.
Small Fiber Neuropathy, Autoimmune Small Fiber Neuropathy, Inflammatory Polyneuropathy, Immune-Mediated Neuropathy
12/26
04/27

Download Options